DEVELOPMENT OF NOVEL, NON‐TOXIC RIFAMYCINS THAT REVERSE DRUG RESISTANCE IN DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL). (June 2017)

• Record Type: Journal Article
• Authors: Maxwell, S.A.; Wallis, D.; Zhou, N.; Baker, D.; Mousavi‐Fard, S.; Loesch, K.; Galaviz, S.; Sun, Q.; Threadgill, D.M.; Rojas, C.M.; O'Brien, M.; Clubb, F.J.; Ioerger, T.; DeJesus, M.; Dong, W.; Seemann, G.; Fossum, T.; Sacchettini, J.C.
• Is Part Of: Hematological oncology. Volume 35(2017)Supplement 2
• Page Start: 253
• Page End: 254
• Publication Date: 2017-06
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.2438_118
• Languages: English
• ISSNs: 0278-0232